Related Experiment Video

Updated: Aug 8, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

New strategies for enhancing the immunogenicity of tumors

D M Pardoll1

  • 1Johns Hopkins University School of Medicine, Baltimore.

Current Opinion in Immunology
|October 1, 1993
PubMed

Insights

Cancer growth indicates immune system failure against tumor antigens. Novel strategies like genetic modification or vaccines can enhance immune response by targeting these specific tumor antigens.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Cancer cells evade immune detection through various mechanisms.
  • Tumor antigens recognized by T cells are crucial for immune surveillance.
  • A compromised immune response allows tumor progression.

Purpose of the Study:

  • To explore strategies for enhancing anti-tumor immunity.
  • To leverage the understanding of tumor antigens for therapeutic development.
  • To address the failure of the immune system in cancer patients.

Main Methods:

  • Reviewing evidence on T cell-recognized tumor antigens.
  • Investigating genetic modification to enhance tumor immunogenicity.
  • Evaluating the use of recombinant or peptide vaccines.

Main Results:

  • Tumor antigens recognized by T cells are increasingly identified.
  • Genetic modification can potentially boost the immune system's ability to fight cancer.
  • Vaccine-based strategies are viable when specific tumor antigens are known.

Conclusions:

  • Targeting tumor antigens is a promising approach in cancer immunotherapy.
  • Enhancing tumor immunogenicity can overcome immune evasion.
  • Personalized vaccine strategies hold potential for cancer treatment.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Dissociation of Human and Mouse Tumor Tissue Samples for Single-cell RNA Sequencing05:58

Dissociation of Human and Mouse Tumor Tissue Samples for Single-cell RNA Sequencing

Published on: August 16, 2024

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...